You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial

Article metrics

Article menu

This article has a correction. Please see:

XML
Immunotherapy biomarkers
Original research
Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial

 

Online download statistics by month:

Online download statistics by month: May 2021 to September 2025

AbstractFullPdf
May 2021398398138
Jun 2021208208108
Jul 202116916974
Aug 202112812945
Sep 2021818129
Oct 2021808029
Nov 202112612543
Dec 2021848517
Jan 2022818322
Feb 2022696918
Mar 2022768141
Apr 202213614369
May 202210010478
Jun 202211712680
Jul 2022646846
Aug 2022697093
Sep 2022929467
Oct 2022889678
Nov 2022818154
Dec 2022636341
Jan 2023494929
Feb 2023696926
Mar 2023495060
Apr 2023646545
May 2023808047
Jun 202310110135
Jul 2023717139
Aug 2023454625
Sep 2023484819
Oct 2023565629
Nov 2023616131
Dec 2023292924
Jan 2024353626
Feb 2024535328
Mar 2024565695
Apr 2024555653
May 202419419431
Jun 2024484729
Jul 2024929736
Aug 2024515028
Sep 2024373729
Oct 2024565628
Nov 2024343523
Dec 2024767947
Jan 2025515132
Feb 2025373717
Mar 2025575747
Apr 2025919166
May 2025777860
Jun 2025202117
Jul 2025110
Aug 2025100
Sep 2025220
Total415642122271